Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Factor V Leiden Testing and Its Effects on Decision-Making: An Institutional Survey

Tushar Pawar, MD MPH, Ian Garrahy, DO, Anthony Donato, MD MHPE, Amber Stevenson, CMA, Daniel Forman, DO

Blood (2019) 134 (Supplement_1): 4977.

https://doi.org/10.1182/blood-2019-131427

Published: 2019

Journal Articles

Novel Point-Of-Use FXa Assay For Monitoring Anticoagulant Therapy By Oral Factor Xa Inhibitors and Heparin

Nina Lukinova, Ph.D., Mano Venkatesan, Jill White

Blood (2013) 122 (21): 4816.

https://doi.org/10.1182/blood.V122.21.4816.4816

Published: 2013

Journal Articles

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Nathan P Clark, PharmD, FCCP, BCPS, Thomas Delate, PhD, MS, Catherine S Riggs, PharmD, Daniel M Witt, PharmD, FCCP, BCPS, Elaine M Hylek, MD, David A Garcia, MD, Walter Ageno, MD, Francesco Dentali, MD, Mark A. Crowther, MD, MSc, FRCPC

Blood (2013) 122 (21): 1143.

https://doi.org/10.1182/blood.V122.21.1143.1143

Published: 2013

Journal Articles

Increased INR>3.0 In Patients on Warfarin Therapy Is Associated with Acute Changes In the Serum Creatinine and Increased Mortality Rate

Sergey Brodsky, Lee Hebert, Haifeng Wu, James Liu, Kyle Ware, Polina Brodsky, Robert Chen, Jon Von isger

Blood (2010) 116 (21): 819.

https://doi.org/10.1182/blood.V116.21.819.819

Published: 2010

Journal Articles

The Influence of CYP2C9 and VKORC1 1173C/T Genotype on Reversal of Anticoagulation (INR) Following Phytonadione Administration.

Nita A. Limdi, PharmD, MSPH, Ronald T. Acton, PhD, Timothy M. Beasely, PhD, Brian Adler

Blood (2007) 110 (11): 3135.

https://doi.org/10.1182/blood.V110.11.3135.3135

Published: 2007

Journal Articles

Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The Direct Study.

James Douketis, MD, Deborah Cook, MD, Nicole Zytaruks, MSc, Diane Heels-Ansdell, MSc, Mark Crowther

Blood (2007) 110 (11): 304.

https://doi.org/10.1182/blood.V110.11.304.304

Published: 2007

NARROW

Factor V Leiden Testing and Its Effects on Decision-Making: An Institutional Survey

Novel Point-Of-Use FXa Assay For Monitoring Anticoagulant Therapy By Oral Factor Xa Inhibitors and Heparin

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Increased INR>3.0 In Patients on Warfarin Therapy Is Associated with Acute Changes In the Serum Creatinine and Increased Mortality Rate

The Influence of CYP2C9 and VKORC1 1173C/T Genotype on Reversal of Anticoagulation (INR) Following Phytonadione Administration.

Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The Direct Study.

Email alerts

ASH Publications

American Society of Hematology

Factor V Leiden Testing and Its Effects on Decision-Making: An Institutional Survey

Novel Point-Of-Use FXa Assay For Monitoring Anticoagulant Therapy By Oral Factor Xa Inhibitors and Heparin

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Increased INR>3.0 In Patients on Warfarin Therapy Is Associated with Acute Changes In the Serum Creatinine and Increased Mortality Rate

The Influence of CYP2C9 and VKORC1 1173C/T Genotype on Reversal of Anticoagulation (INR) Following Phytonadione Administration.

Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The Direct Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only